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Abstract
Background: Osteoarthritis is a disabling musculoskeletal disease with no definite treatment. This
study compared the effect of Platelet-rich plasma (PRP) and Transcutaneous Electrical Nerve Stimu-
lation (TENS) plus exercise in the treatment of patients with knee joint osteoarthritis.
Methods: 54 eligible patients with knee osteoarthritis were randomly allocated into two groups.
(IRCT2012110611382N)  Group A (27 patients) received 2 injections of PRP (4 weeks apart) and
group B (27 patients) received 10 sessions of TENS as well as exercise during the study period.
Clinical outcome was evaluated using the Knee injury and Osteoarthritis Outcome Scores (KOOS)
questionnaire before the treatment, 4 weeks, and 8 weeks after that the treatment. Pain was also as-
sessed using a visual analog scale (VAS). Time to an intolerable knee pain during treadmill workout
was also evaluated using an objective test.
Results: In the PRP group, the mean KOOS symptom score improved significantly from baseline to
the end of study, while the change was not significant over this period for the group B. In both
groups, significant reductions were observed in VAS scores from baseline till the end of study. The
mean time to feel intolerable knee pain during treadmill work out of PRP group increased signifi-
cantly from baseline to week 4, but no significant changes were found in this parameter over the time
of study in the group B.
Conclusion: Intraarticular injection of PRP is an effective, safe method for short-term treatment of
patients with knee joint osteoarthritis.
Keywords: Platelet - rich Plasma, PRP, Knee Osteoarthritis, Exercise.
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Introduction
Osteoarthritis (OA) of knee is one of the
most common debilitating conditions asso-
ciated with pain and limitation in daily liv-
ing activities which negatively affect quali-
ty-of-life. Although different kinds of non-
surgical options including analgesics, ster-
oid and nonsteroid anti-inflammatory
drugs, glucosamine, chondroitin sulphate
and hyaluronic acid are currently available
for the treatment of knee joint osteoarthri-
tis, they are mainly aimed at the sympto-
matic relief, but not joint cartilage regener-
ation (1). Therefore, there is an urgent need
for new procedures that are not only cost
effective, but also targeting the biochemical
process of OA as well as joint cartilage re-
generation.  Due to the ability of matrix
synthesis enhancement, the use of growth
factors has been broadly considered for car-
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tilage repair (2). Autologous Platelet-Rich
Plasma (PRP) is the volume of plasma with
a high platelet concentration above normal
baseline values (3). Platelets are sources of
high concentrations of cytokines and a
group of growth factors which regulate
healing processes as well as tissue regener-
ation (4). PRP therapy provides a highly
concentrated mixture of growth factors to
contribute with healing process. Some
growth factors in PRP such as transforming
growth factor –β seem to be correlated with
chondrogenesis in cartilage repair (5, 6).
PRP also contains plasmatic proteins,
which is believed to boost or stimulate
healing process that is very similar to the
process which normally occurs in the hu-
man body following injury (5, 7). However,
most studies on PRP therapy are under-
powered, nonrandomized, or engage insuf-
ficient sample sizes which make them unre-
liable (5, 6). Moreover, while there are rela-
tively good evidences (5, 8) regarding the
beneficial effects of PRP on chronic, non-
healing tendon injuries including lateral
epicondylitis and plantar fasciitis, very few
powered studies have pointed toward the
safety and efficacy of an intraarticular in-
jection of PRP for the treatment of knee
OA. On the other hand the majority of stud-
ies (9, 10) used expensive and time-
consuming techniques to provide PRP
which make it hard to apply these tech-
niques in ordinary clinical settings. There-
fore, this clinical trial was conducted to in-
troduce a simple, low-cost protocol for PRP
preparation as well as to determine its effi-
cacy and safety for short-term treatment of
knee OA.
Methods
Research Design
This study was a randomized clinical trial
(IRCT2012110611382N) with 2 groups
receiving different kinds of treatment. Prior
to study all subjects were asked to sign an
informed consent which was approved by
the Ethics Committee of the Iran University
of Medical Sciences.  Besides this clinical
trial has the code number (IRCT
2012110611382N) in IRCT. Subjects were
randomly allocated to receive a standard-
ized PRP injection protocol or a conven-
tional treatment approach including TENS
and exercise therapy. All participants were
assessed on a number of subjective and ob-
jective variables (Knee injury and Osteoar-
thritis Outcome Scores (KOOS), visual
analog scale (VAS) for pain, time to feel
intolerable knee pain during treadmill
workout, and adverse effects) before the
treatment and at 4 weeks and 8weeks after
that.
Sampling
The present study was conducted on pa-
tients presenting the sports and exercise
medicine outpatient clinic of the Hazrat Ra-
sool-e-Akram hospital. Patients with knee
OA as diagnosed by American College of
Rheumatology criteria (11) and graded as
per Kellgren and Lawrence radiographic
scoring system (12) were voluntarily en-
rolled in this study. 54 patients who had
OA of the knee according to the criteria
were selected on the basis of predefined
inclusion criteria, that were, grade 1, 2 and
3 knee osteoarthritis based on Kellgren and
Lawrence radiographic scoring system, no
history of corticosteroid injection or con-
sumption within past 6 months, no history
of peripheral vascular disease, spinal steno-
sis, severe disabilities, inflammatory and
metabolic diseases and lack of history of
anticoagulative drugs consumption or co-
agulopathies. Exclusion criteria were con-
sumption or intra-articular injection of cor-
ticosteroids during the study, anticoagula-
tive drugs consumption during the study,
and patient request for leaving the study.
The sample size was calculated based on
an assumed study power of 80% (β=0.2), a
false-positive rate of 5% (α=0.05), and a
predicted difference of 2 points on our
VAS (standard deviation, ±2). Using these
parameters, and adjusting α for multiple
comparisons, as well as including the
possible loss of 25% of the samples during
the study, we required 27 patients for each
group.
D
ow
nl
oa
de
d 
fro
m
 m
jiri
.iu
ms
.ac
.ir 
at 
9:1
6 I
RS
T o
n W
ed
ne
sd
ay
 Ja
nu
ary
 1s
t 2
02
0
H. Angoorani, et al.
3MJIRI, Vol. 29.223. 27 June 2015 http://mjiri.iums.ac.ir
The samples were randomly divided into
two groups using a computer derived ran-
dom chart: 27 participants in group A (PRP
group) were given two intra-knee injections
of PRP 4 weeks apart, 27 participants in
group B (TENS group) received 10 sections
of TENS, twice a week with a frequency of
100 hertz for 30 minutes in each section.
Moreover all patients in group B received a
specialized exercise program on a compact
disk (CD) as well as in a guided booklet.
These subjects were asked to do their daily
knee resistance and flexibility exercises in
3 sets of 10 repetitions and 1 set of 5 repeti-
tions, respectively. Among 27 patients in
PRP group, 1 patient was excluded as she
had an anterior cruciate ligament (ACL)
injury due to a trauma. Of the 27 patients in
group B, 3 patients refused the treatment,
and 24 patients remained in the study (Fig.
1).
The baseline characteristics of the two
groups were similar with respect to age,
sex, weight, and height and body mass in-
dex (Table 1).
PRP Preparation
The PRP required for injection was pre-
pared by the Sports Medicine clinic of the
Hazrat Rasool-e-Akram hospital in Tehran.
About 22.5 mL of venous blood was drawn
under sterile protection from the upper ex-
tremities veins meticulouslyin order to
avoid any unwanted trauma to the platelets.
The blood was collected in a syringe with
2.5 mL ACD (Anticoagulant Citrate Dex-
trose) as an anticoagulant. The whole blood
was slowly transferred using an 18 gauge
needle from the syringe into a 25-mL ster-
ile Tubex tube (a PRP kit which is made in
South Korea and approved by Iran Health
Ministry). The tubes were then centrifuged
Fig. 1. Flow chart of recruiting patients in this study
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for 6 minutes at 1600 rpm for women and
1800 rpm for men on the Celex centrifuge,
and the blood was separated into PRP and
residual red blood cells with the buffy coat.
In this step the upper part of tube (plasma)
was separated from the lower part (red
blood cells) via locking the middle part of
tube and then the tubes were centrifuged
again for 5 minutes at 2000 rpm. Of 10 to
12 mL remained liquid in the upper part of
tube, about 6 mL of plasma in the upper
part was extracted via a 14 gauge angio-
catheter and the remained liquid was shiv-
ered slowly till a homogenous solution was
obtained. Finally this platelet enrich ho-
mogenous solution was extracted via a 10
mL syringe. Moreover, 0.5 mL of the pa-
tient’s peripheral blood as well as the final
PRP was sent to the laboratory in order to
measure the total platelet count. Platelet
count was increased between 3 to 7 times
than that of baseline in all samples; there-
fore, PRP with a platelet count of at least 3
times comparing to the baseline was inject-
ed in all.
Intervention
The patient was placed in a supine posi-
tion with the knee in 45 degree flexion.
Under sterile conditions, 5 mL of PRP
(which was activated by 0.5 mL calcium
gluconate immediately before injection)
was slowly injected inside the knee through
the infero-medial or infero-lateral approach
with a 21- gauge needle without local anes-
thetic. The patients were discharged after
30 minutes of observation while using a
wheelchair in order to leave the clinic.
None of the patients reported complications
like dizziness, nausea, headache and sweat-
ing after injection. During the follow-up
period, nonsteroidal anti-inflammatory
drugs (NSAIDs), antiplatelet drugs and ice
were not allowed, and paracetamol (500 mg
orally three times a day during the first 72
hours after injection) was prescribed in case
of discomfort. Also all patients were asked
to avoid green tea and cranberry use as well
as discontinue NSAIDs 72 hours and an-
tiplatelet drugs such as aspirin 10 days be-
fore injection. Patients were strongly rec-
ommended to contact with us in case of oc-
curring any adverse effect such as, fever,
intolerable pain, redness and swelling.
Outcome Measures
The primary efficacy criteria were change
from baseline in terms of pain, other symp-
toms, function in sport and recreation and
knee related quality of life, measured using
the KOOS subscales. The KOOS parame-
ters were measured before the first and the
second injection, and also at 4 weeks after
the second injection. Patients were also as-
sessed for pain using VAS and time to feel
intolerable knee pain during treadmill
workout (walking on treadmill with a speed
of 3 km/h and grade 0 till to fell intolerable
knee pain) before the first and the second
injection, and also at 4 weeks after the se-
cond injection. Moreover all subjects were
asked to wear a sports shoe for the tread-
mill test and avoid vigorous physical activi-
ty within 24 hours prior to the test. Adverse
effects related to treatment were also rec-
orded in every visit.
Table 1. Baseline characteristics of the participants
Characteristics TENS group
(n=27)
PRP group
(n=27)
p
Gender, No. (%) 0.42
Female 25 (92.6%) 22 (81.5%)
Male 2 (7.4%) 5 (18.5%)
Age (year) 61.59±8.07(range 44-80) 62.15±12.14 (range 43-80) 0.84
Height (cm) 160.04±6.20 160.41±8.21 0.85
Weight (kg) 74.96±10.97 73.92±14.66 0.77
BMI (kg/m2) 29.21±3.22 28.52±3.83 0.48
Note: TENS group, exercise therapy with TENS modality group; PRP group, exercise therapy plus PRP group; BMI, Body
Mass Index, Quantitative data are presented as Mean ± Standard deviation
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Statistical Analysis
To compare baseline demographics of the
two groups, independent sample t-test for
continuous variables and Pearson chi-
square test for nominal variables was ap-
plied. The normality assumption of the con-
tinuous variables was checked using the
Shapiro-Wilk test.
Generalized Estimating Equation (GEE)
models were fitted to examine the associa-
tions between type of therapy and change
in the Knee injury and osteoarthritis out-
come scores (KOOS), VAS pain scores and
time to feel knee pain over time. GEE
models included two main effects (type of
therapy and time) and the interaction of
these effects. Time points in the analyses
included baseline and visits of weeks 4 and
8. Using GEE, the correlation of multiple
measurements within one patient is taken
into account.
All tests applied were two-sided and a
significance level of 0.05 was considered
significant. All statistical analysis were per-
formed with statistical software SPSS
16.0.0. (SPSS Inc. Chicago, IL, USA).
Results
Fifty-four eligible patients with knee os-
teoarthritis were included into the study
who were randomly allocated into two
groups. The baseline characteristics of the
participants are summarized in table 1.
Twenty-four patients in TENS group and
26 patients in PRP group attended at least
one of the pre-determined visits (visits of
weeks 4 and 8) after the baseline visit. The
process of enrollment and accomplishment
of study is illustrated in Fig.1.
Knee injury and osteoarthritis outcome
scores (KOOS)
In the PRP group, the mean KOOS
symptom score improved significantly from
baseline to week 4, while the change was
not significant over this period for the
TENS group. In addition, no significant
changes were observed in this subscale
from week 4 to week 8 in both groups (Ta-
ble 2). Compared to the TENS group, the
PRP group had a greater improvement in
the mean KOOS symptom score from base-
line to week 4 (mean difference 10.7
points, p=0.010, table 3). However, the pat-
tern of change of this parameter was similar
between the two groups from week 4 to
week 8 (p=0.060). The patterns of change
of the other KOOS subscales’ scores did
not differ significantly over time between
the two groups (no group×time interactions,
Table 2. Knee injury and osteoarthritis outcome scores (KOOS) over time in the two study groups
Variables Time of study p*
Baseline Week 4 Week 8
Pain 0.59
TENS group 41.3 (3.43) 46.7 (3.14) £ 44.2 (3.88)
PRP group 44.9 (3.56) 54.4 (4.15) £ 50.7 (3.24)
Symptoms 0.047
TENS group 50.3 (3.87) 51.7 (3.56) 52.0 (3.96)
PRP group 51.5 (4.47) 63.6 (4.23) £ 61.5 (3.86)*
ADL 0.44
TENS group 42.4 (4.09) 46.9 (3.68) 44.2 (4.36)
PRP group 48.3 (3.81) 58.7 (4.08) £ 54.4 (3.35)
Sport/Rec 0.99
TENS group 28.4 (6.16) 27.6 (6.11) 25.4 (5.31)
PRP group 23.8 (4.87) 22.9 (4.68) 21.3 (4.33)
QOL 0.12
TENS group 20.6 (3.65) 18.4 (2.68) 17.6 (2.58)
PRP group 17.1 (2.62) 23.0 (3.14) 22.6 (2.49)
* The P-value for Group×Time interaction (Based on the results of GEE analysis)
The values are expressed as mean (SD).
Note: TENS group: exercise therapy with TENS modality group. KOOS consists of five subscales; pain, other symp-
toms, function in sport and recreation (Sport/Rec) and knee related quality of life (QOL). A normalized score (range 0
to 100 with 0 indicating extreme problems and 100 indicating no problem) is calculated for each subscale.
£ p<0.05 for statistical difference from baseline to week 4 within the group.
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Table 2). After 4 weeks of interventions,
significant improvements were observed in
the KOOS pain scores of both groups.
However, the mean pain scores of both
groups did not change significantly from
week 4 to week 8 (Table 2). Patients in the
PRP group experienced a significant im-
provement in the mean KOOS ADL score
from baseline to week 4 and this improve-
ment was maintained up to week 8. In con-
trast, no significant change was found in
the mean scores of this item over time in
the TENS group (Table 2). Both interven-
tions had no effects on KOOS Sport/Rec
and QOL subscales (Tables 2 and 3).
Changes of KOOS from baseline to the
end of study
In the PRP group, the mean KOOS symp-
tom score improved significantly from
baseline to the end of study, while the
change was not significant over this period
for the TENS group (p=0.010 and p=0.450,
respectively). In both groups, no significant
change was observed in other KOOS sub-
scales from baseline till the end of study
(Table 2).
VAS pain score
The pattern of change of VAS pain scores
was not significantly different over the
course of study between the two groups (no
group×time interaction; p=0.900). Pain re-
lief (according to VAS) was observed at the
first month of study in both groups (both
p<0.0001). However, no significant im-
provement was found in VAS scores of the
two groups from week 4 till the end of the
study (Fig. 2). In both groups, significant
reductions were observed in VAS scores
from baseline till the end of study (Fig. 2).
Time to feel intolerable pain during
treadmill workout
The mean time to feel knee intolerable
pain during treadmill workout in the PRP
group increased significantly from baseline
to week 4 (p<0.001) and remained un-
changed till week 8 (mean (SD): 10.07
(1.52) at baseline; 15.86 (1.41) at week 4
and 17.06 (1.51) minutes at week 8). How-
ever, no significant change was found in
this parameter over the time of study in the
TENS group (mean (SD): 13.09 (2.52) at
baseline; 13.05 (1.84) at week 4 and 12.72
(1.74) minutes at week 8). The PRP group
in comparison with the TENS group had an
additional 5.8 minutes increase in the mean
time to feel pain from baseline to week 4
(group×time interaction, p=0.04).
Table 3. GEE results of the effects of PRP in comparison with the exercise therapy with TENS modality on knee injury
and osteoarthritis outcome scores (KOOS)
Variables Group Week Estimate (SE) 95% CI p
Lower bound Upper
Pain
Group× Week* PRP group 4 4.1 (4.03) -3.77 12.02 0.31
Group× Week PRP group 8 2.9 (5.41) -7.70 13.50 0.59
Symptoms
Group× Week PRP group 4 10.7 (4.35) 2.17 19.22 0.01
Group× Week PRP group 8 8.3 (4.46) -0.42 17.09 0.06
ADL
Group× Week PRP group 4 5.9 (4.65) -3.19 15.04 0.20
Group× Week PRP group 8 4.3 (5.71) -6.91 15.48 0.45
Sport/Rec
Group× Week PRP group 4 -.,2 (8,37) -16.58 16.24 0.98
Group× Week PRP group 8 0.5 (6.74) -12.73 13.68 0.94
QOL
Group× Week PRP group 4 8.0 (4.30) -0.37 16.48 0.06
Group× Week PRP group 8 8.5 (4.57) -0.49 17.42 0.06
* For ease of interpretation, the baseline (week 0) and the TENS group are considered as the reference levels for time and
intervention group, respectively.
Note: TENS group, exercise therapy with TENS modality group. KOOS consists of five subscles; pain, other symptoms,
function in sport and recreation (Sport/Rec) and knee related quality of life (QOL). A normalized score (range 0 to 100
with 0 indicating extreme problems and 100 indicating no problem) is calculated for each subscale.
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Mild complications such as little swelling
and pain, were observed in 3 patients (11%)
in PRP group and 1 patient (4%) in TENS
plus exercise group. No severe complica-
tion was observed in both groups.
Discussion
There are limited surveys suggesting clin-
ical effectiveness of PRP for short-term
symptomatic relief in patients with knee
osteoarthritis. Moreover, these studies are
mainly of poor quality and at high risk for
bias. The majority of studies on this topic
are non- randomized or without a con-
trolled group; those studies with a con-
trolled group, used intra-knee injection of
hyaluronic acid or normal saline as the con-
trolled method (13, 14). To our knowledge
this is the first study which compared the
effect of PRP with TENS and exercise in
short-term treatment of patients with knee
joint osteoarthritis. The combination of
physical therapy modalities such as,
Transcutaneous Electrical Nerve Stimula-
tion (TENS) and exercise is a common well
known method of treatment in patients with
knee osteoarthritis. Pietrosimone et al
showed that the combination of TENS and
exercise is more effective in short-term
treatment of knee osteoarthritis compared
with exercise alone (15,16). Regarding the
treatment of knee osteoarthritis, Chen et al
reported that TENS plus exercise is more
effective than intra-knee injection of hyalu-
ronic acid (17). It seems that there is
enough evidence avilable (15-20) in sup-
porting the effectiveness of TENS and ex-
ercise in symptomatic relief of patients with
knee joint osteoarthritis. The present study
showed that PRP is even more effective in
short term treatment of knee joint osteoar-
thritis in comparison with combination of
TENS and exercise. Nearly all of previous
studies showed that compared with hyalu-
ronic acid or placebo injection, intra-
articular PRP injections have more benefi-
cial effects in the short-term treatment of
patients with knee OA (10, 13, 21, 22); this
can be rational to observe such a result in
the present study. Moreover in order to
evaluate the effectiveness of PRP objec-
tively, we assessed the time to feel intoler-
able pain during treadmill workout in addi-
tion to the ordinary subjective measured
outcomes such as KOOS and VAS. Based
on our result, in comparison with TENS
and exercise, PRP injections significantly
increased the mean time to feel pain during
Fig. 2. VAS pain score, comparison between PRP and TENS group
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treadmill workout. This finding showed
that the patients who received PRP injec-
tions for the treatment of KO, not only feel
better, but also actually achieve a better
performance. To our Knowledge, none of
the previous studies used the objective
method like this to assess PRP effective-
ness in the treatment of knee osteoarthritis.
Interestingly we found that, although the
mean KOOS symptom score improved sig-
nificantly from the baseline to week 4
merely in the PRP group, this improvement
stopped from week 4 to week 8 even in the
PRP group.  According to the study of
Sundman, et al., (23), this significant short
term symptomatic relief in the PRP group
seems to be due to suppression of inflam-
matory mediators; however this phenome-
non may decrease after several weeks.
The most important limiting factors in
this study were short-term follow-up as
well as lack of blindness. However in the
present study, we compared the short term
effect of PRP with a very common thera-
peutic approach (TENS plus exercise) for
KO in our country, which makes this sur-
vey unique.
Conclusion
Intraarticular injection of PRP is an effec-
tive, safe method for the short-term treat-
ment of patients with knee joint osteoarthri-
tis. More double blinded randomized clini-
cal trials are needed before widespread use
of PRP for the treatment of knee joint oste-
oarthritis.
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